Skip to main content
. 2018 Dec 14;16:356. doi: 10.1186/s12967-018-1724-z

Fig. 4.

Fig. 4

Box plot analysis of AR expression on CETCs in breast cancer patients with respect to lymph node and hormone receptor status. a We identified significant enhanced number of AR positive CETCs in patients without lymph node metastasis (N−) as compared to patients with lymph node involvement (N+), *P < 0.05. b In TNBC patients we observed elevated numbers of AR positive CETCs as compared to patients with HR positive primary tumors, *P < 0.05